Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation

Area of Science:

• Immunology
• Oncology
• Cancer Immunotherapy

Background:

• Natural killer (NK) cells are crucial for inhibiting tumor development and their presence correlates with patient survival.
• Tumor-associated NK cells often exhibit dysfunction, making their stimulation a promising immunotherapeutic approach.
• In lung adenocarcinoma mouse models, NK cells in tumors show immature phenotypes and low functional capacity.

Purpose of the Study:

• To investigate the responsiveness of NK cells within established tumors.
• To assess the impact of NK cell stimulation on the tumor microenvironment and adaptive immunity.
• To evaluate NK cell-based immunotherapy for established lung adenocarcinoma.

Main Methods:

• Engineered a system for inducible expression of activating ligands in mouse lung adenocarcinoma tumors.
• Analyzed NK cell localization, phenotype, and cytokine production post-stimulation.
• Assessed T cell recruitment and functionality in response to NK cell activation.
• Evaluated tumor growth in long-term settings, particularly in neoantigen-expressing tumors.

Main Results:

• Stimulated NK cells localized within tumors and demonstrated increased cytokine production.
• NK cell activation led to the recruitment of T cells into tumors, enhancing their functionality.
• In neoantigen-expressing tumors, NK cell stimulation increased the number and function of tumor-specific T cells.
• Long-term NK cell stimulation resulted in reduced tumor growth.

Conclusions:

• NK cells can be effectively activated within established tumors to bolster antitumor immunity.
• NK cell stimulation promotes T cell recruitment and enhances their anti-tumor functions.
• Targeting NK cells represents a viable strategy for cancer immunotherapy, even in advanced disease stages.